Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1

C Liu, L Liu, X Chen, J Shen, J Shan, Y Xu, Z Yang… - PloS one, 2013 - journals.plos.org
DNA methylation is an important epigenetic modification and is frequently altered in cancer.
Convert of 5-methylcytosine (5 mC) to 5-hydroxymethylcytosine (5 hmC) by ten-eleven …

[HTML][HTML] TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma

A Murata, Y Baba, T Ishimoto, K Miyake, K Kosumi… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Mammalian DNA is epigenetically marked by 5′-cytosine methylation (5-methylcytosine [5-
mC]). The Ten-eleven translocation (TET) enzymes (TET1, TET2, and TET3) are implicated …

Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients

Q Yang, K Wu, M Ji, W Jin, N He, B Shi… - J Biomed …, 2013 - ingentaconnect.com
DNA methylation at the 5 position of cytosine (5-mC) is a key epigenetic mark that is
involved in various biological and pathological processes. 5-mC can be converted to 5 …

Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation

Y Kudo, K Tateishi, K Yamamoto, S Yamamoto… - Cancer …, 2012 - Wiley Online Library
Dysregulated DNA methylation followed by abnormal gene expression is an epigenetic
hallmark in cancer. DNA methylation is catalyzed by DNA methyltransferases, and the …

5-hydroxymethylcytosine: a new insight into epigenetics in cancer

C Ye, L Li - Cancer biology & therapy, 2014 - Taylor & Francis
DNA methylation at the 5 position of cytosine (5-mC) has emerged as a key epigenetic
marker that plays essential roles in various biological and pathological processes. 5-mC can …

Ten–eleven translocase: key regulator of the methylation landscape in cancer

J Shekhawat, K Gauba, S Gupta, B Choudhury… - Journal of cancer …, 2021 - Springer
Purpose Methylation of 5th residue of cytosine in CpG island forms 5-methylcytosine which
is stable, heritable epigenetic mark. Methylation levels are broadly governed by …

Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation

H Yang, Y Liu, F Bai, JY Zhang, SH Ma, J Liu, ZD Xu… - Oncogene, 2013 - nature.com
The TET (ten–eleven translocation) family of α-ketoglutarate (α-KG)-dependent
dioxygenases catalyzes the sequential oxidation of 5-methylcytosine (5mC) to 5 …

[PDF][PDF] Global DNA 5‐hydroxymethylcytosine and 5‐formylcytosine contents are decreased in the early stage of hepatocellular carcinoma

J Liu, J Jiang, J Mo, D Liu, D Cao, H Wang, Y He… - …, 2019 - Wiley Online Library
Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of
DNA. It has been shown that the oxidized derivatives of 5mC, namely 5 …

[HTML][HTML] Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis

Z Chen, X Shi, L Guo, Y Li, M Luo, J He - Oncotarget, 2017 - ncbi.nlm.nih.gov
Ten-eleven translocation (TET) enzymes catalyze the oxidation of 5-methylcytosine (5-mC)
to 5-hydroxymethylcytosine (5-hmC) and then to 5-formylcytosine (5-fC) and 5 …

TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells

J Wu, H Li, M Shi, Y Zhu, Y Ma, Y Zhong… - Journal of Experimental …, 2019 - Springer
Background Ten-eleven translocation 1 (TET1) is a dioxygenase that converts 5-
methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) to induce DNA demethylation …